Asia Pacific Genome Sequencing Market 2020-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity

  • Product Code:
    RP-ID-10352327
  • Published Date:
    7 Jan 2022
  • Region:
    Regional
  • Pages:
    109
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-26

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

The Research Report is Updated with 2021 Base Year, 2022 Estimated year and Forecast till 2031 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2021 as base year, 2022 as estimated year and forecast to 2031. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Translate Report

Asia Pacific genome sequencing market will grow by 15.6% annually with a total addressable market cap of $38.26 billion over 2021-2030 owing to the growing government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing, and the utilization of genomics in specialized or personalized medicine.
Highlighted with 30 tables and 52 figures, this 109-page report “Asia Pacific Genome Sequencing Market 2020-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific genome sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific genome sequencing market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Consumables
• Sequencers & Software
• Service

Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Polymerase Chain Reaction (PCR)
• Sequencing
• Microarray
• Nucleic Acid Extraction and Purification
• Other Technologies

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Diagnostics
o Oncology
o Reproductive Health
o Complex Disease Research
o Other Diagnostics
• Drug Discovery and Development
• Precision Medicine
• Agriculture and Animal Research
• Other Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Academic & Research Centers
• Pharmaceutical and Biotechnology Companies
• Consumer Genomic Service Providers
• Government Institutes
• Other End Users

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Product, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
BGI
Biomatters
Bio-Rad Laboratories, Inc.
DNASTAR
F. Hoffmann-La Roche
Illumina, Inc.
Macrogen Inc.
Myriad Genetics, Inc.
New England Biolabs
Oxford Nanopore Technology
PerkinElmer Inc.
Qiagen
Siemens Healthineers
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)



.

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39
3 Segmentation of Asia Pacific Market by Product 43
3.1 Market Overview by Product 43
3.2 Consumables 45
3.3 Sequencers & Software 46
3.4 Service 47
4 Segmentation of Asia Pacific Market by Technology 48
4.1 Market Overview by Technology 48
4.2 Polymerase Chain Reaction (PCR) 50
4.3 Sequencing 51
4.4 Microarray 52
4.5 Nucleic Acid Extraction and Purification 53
4.6 Other Technologies 54
5 Segmentation of Asia Pacific Market by Application 55
5.1 Market Overview by Application 55
5.2 Diagnostics 57
5.2.1 Oncology 59
5.2.2 Reproductive Health 60
5.2.3 Complex Disease Research 61
5.2.4 Other Diagnostics 62
5.3 Drug Discovery and Development 63
5.4 Precision Medicine 64
5.5 Agriculture and Animal Research 65
5.6 Other Applications 66
6 Segmentation of Asia Pacific Market by End User 67
6.1 Market Overview by End User 67
6.2 Academic & Research Centers 69
6.3 Pharmaceutical and Biotechnology Companies 70
6.4 Consumer Genomic Service Providers 71
6.5 Government Institutes 72
6.6 Other End Users 73
7 Asia-Pacific Market 2019-2030 by Country 74
7.1 Overview of Asia-Pacific Market 74
7.2 Japan 77
7.3 China 80
7.4 Australia 82
7.5 India 84
7.6 South Korea 86
7.7 Rest of APAC Region 88
8 Competitive Landscape 90
8.1 Overview of Key Vendors 90
8.2 New Product Launch, Partnership, Investment, and M&A 93
8.3 Company Profiles 94
BGI 94
Biomatters 96
Bio-Rad Laboratories, Inc. 97
DNASTAR 98
F. Hoffmann-La Roche 99
Illumina, Inc. 100
Macrogen Inc. 101
Myriad Genetics, Inc. 102
New England Biolabs 103
Oxford Nanopore Technology 104
PerkinElmer Inc. 105
Qiagen 106
Siemens Healthineers 107
Thermo Fisher Scientific 108
RELATED REPORTS 109

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Key Players (this may not be a complete list and extra companies can be added upon request):
BGI
Biomatters
Bio-Rad Laboratories, Inc.
DNASTAR
F. Hoffmann-La Roche
Illumina, Inc.
Macrogen Inc.
Myriad Genetics, Inc.
New England Biolabs
Oxford Nanopore Technology
PerkinElmer Inc.
Qiagen
Siemens Healthineers
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports